12 June 2014
Physiomics is pleased to announce that it has signed a Heads of Terms agreement with Diatech Pharmacogenetics to negotiate a Collaboration Agreement. Under the terms of the anticipated Collaboration Agreement Physiomics and Diatech will develop an innovative in-silico platform to personalize cancer patient treatment. This anticipated new in-silico platform will combine pharmacological information related to […]
9 May 2014
Dr Mark Chadwick, CEO and Dr Christophe Chassagnole, COO will both present at Biotrinity 2014. Dr Chadwick will present our latest technologies in the Company showcase on the 14th of May at 13:50 and Dr Christophe Chassagnole will present on Virtual Tumour Clinical in the TSB showcase on the 13th of May at 15:20.
15 April 2014
Physiomics will present a half-day workshop on “Applications of Physiomics’ Virtual Tumour Clinical within Translational Science”, on the June 10, 1:30 pm – 4:30 pm ahead of the 2014 PAGE meeting that will take place in Alicante (Spain). This workshop will review the preclinical Virtual Tumour model used to predict optimal doses and schedules of […]
10 April 2014
Physiomics is pleased to announce that it is presenting at the CASyM Academic / Industry interaction workshop taking place in Lyon (France) on April 10th 2014. Dr Hitesh Mistry will present on validation of the Virtual Tumour Clinical platform in melanoma to an audience that will comprise senior academics and large pharmaceutical company scientists. Read […]
3 April 2014
Physiomics is pleased to announce that it is participating in the AACR Annual Meeting 2014, taking place at the San Diego Convention Center, San Diego, CA on 5-9 April 2014. Dr Eric Fernandez will present on the first validation of the Virtual Tumour Clinical platform. Read more.
14 February 2014
The Board of Physiomics today announces its interim financial results for the six months ended 31 December 2013. Read more.
16 January 2014
Physiomics plc is pleased to announce that it has signed a collaboration agreement with the University of Dundee. Physiomics part of the collaboration will be fully funded by the Northern Research Partnership (“NRP”) in the form of an “Early Career Researcher Engagement and Exchanges with Business & Industry” agreement. Read more.